| 380 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| 697 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| 5637 |
urinary tract |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| 22RV1 |
prostate |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| 23132-87 |
stomach |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| 639-V |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| 647-V |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| 769-P |
kidney |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| 786-0 |
kidney |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| 8505C |
thyroid |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| 8-MG-BA |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| A101D |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| A172 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| A204 |
soft tissue |
Myomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| A2058 |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| A253 |
salivary gland |
Mucoepidermoid neoplasms |
GSE36133/Sanger Cell Line Project |
| A2780 |
ovary |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| A375 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| A3-KAW |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| A427 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| A431 |
skin |
Squamous cell neoplasms |
Sanger Cell Line Project |
| A498 |
kidney |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| A4-Fuk |
haematopoietic and lymphoid tissue |
Lymphoid leukemia |
GSE36133/Sanger Cell Line Project |
| A549 |
lung |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| A673 |
bone |
Miscellaneous bone tumors |
GSE36133/Sanger Cell Line Project |
| A704 |
kidney |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| ABC-1 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| ACHN |
kidney |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| ACN |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| AGS |
stomach |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| ALL-PO |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| AM-38 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| AML-193 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| AN3-CA |
endometrium |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| ARH-77 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
Sanger Cell Line Project |
| AsPC-1 |
pancreas |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| ATN-1 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| B2-17 |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| BALL-1 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| BB30-HNC |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| BB49-HNC |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| BB65-RCC |
kidney |
Adenocarcinoma |
Sanger Cell Line Project |
| BC-1 |
haematopoietic and lymphoid tissue |
Malignant lymphoma |
Sanger Cell Line Project |
| BC-3 |
haematopoietic and lymphoid tissue |
Malignant lymphoma |
Sanger Cell Line Project |
| BCPAP |
thyroid |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| BE-13 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| Becker |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| BEN |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| BFTC-905 |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| BFTC-909 |
kidney |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| BHT-101 |
thyroid |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| BHY |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| BL-41 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| BL-70 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| BOKU |
cervix |
Squamous cell neoplasms |
Sanger Cell Line Project |
| BONNA-12 |
haematopoietic and lymphoid tissue |
Other leukemias |
Sanger Cell Line Project |
| BPH-1 |
prostate |
Hyperplasia |
Sanger Cell Line Project |
| BT-20 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| BT-549 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/NCI60/Sanger Cell Line Project |
| BV-173 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| BxPC-3 |
pancreas |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| C2BBe1 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| C32 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| C-33-A |
cervix |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| C3A |
liver |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| C-4-II |
cervix |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| C8166 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| CA46 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| Ca9-22 |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| CAKI-1 |
kidney |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| CAL-120 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CAL-12T |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CAL-148 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CAL-27 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| CAL-33 |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| CAL-39 |
vulva |
Squamous cell neoplasms |
Sanger Cell Line Project |
| CAL-51 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CAL-54 |
kidney |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| CAL-62 |
thyroid |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CAL-72 |
bone |
Osseous and chondromatous neoplasms |
Sanger Cell Line Project |
| CAL-85-1 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| Calu-1 |
lung |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| Calu-3 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| Calu-6 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CAMA-1 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| Caov-3 |
ovary |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| Caov-4 |
ovary |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| CAPAN-1 |
pancreas |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| CAPAN-2-DSMZ-C |
pancreas |
Adenocarcinoma |
Sanger Cell Line Project |
| CaR-1 |
large intestine |
Adenocarcinoma |
Sanger Cell Line Project |
| CAS-1 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| Ca-Ski |
cervix |
Squamous cell neoplasms |
Sanger Cell Line Project |
| CCF-STTG1 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| CCRF-CEM |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
NCI60/Sanger Cell Line Project |
| CESS |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
Sanger Cell Line Project |
| CFPAC-1 |
pancreas |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| CGTH-W-1 |
thyroid |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| ChaGo-K-1 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CHL-1 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| CHP-126 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| CHP-134 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| CHP-212 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| CMK |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| CML-T1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| COLO-205 |
large intestine |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| COLO-320-HSR |
large intestine |
Adenocarcinoma |
Sanger Cell Line Project |
| COLO-668 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| COLO-678 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| COLO-679 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| COLO-680N |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| COLO-684 |
endometrium |
Adenocarcinoma |
Sanger Cell Line Project |
| COLO-720E |
ovary |
Adenocarcinoma |
Sanger Cell Line Project |
| COLO-741 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| COLO-792 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| COLO-800 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| COLO-824 |
breast |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| COR-L105 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| COR-L23 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| COR-L279 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| COR-L51 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| COR-L88 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| COR-L96CAR |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| CP66-MEL |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| CP67-MEL |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| CPC-N |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| CRO-AP2 |
haematopoietic and lymphoid tissue |
Malignant lymphoma |
Sanger Cell Line Project |
| CRO-AP5 |
haematopoietic and lymphoid tissue |
Malignant lymphoma |
Sanger Cell Line Project |
| CTB-1 |
haematopoietic and lymphoid tissue |
Malignant lymphoma |
Sanger Cell Line Project |
| CTV-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
Sanger Cell Line Project |
| CW-2 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| D-245MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-247MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-263MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-283MED |
central nervous system |
Miscellaneous bone tumors |
GSE36133/Sanger Cell Line Project |
| D-336MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-384MED |
central nervous system |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| D-392MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-397MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-423MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-458MED |
central nervous system |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| D-502MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-538MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-542MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| D-556MED |
central nervous system |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| D-566MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| Daoy |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| Daudi |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| DB |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| DBTRG-05MG |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| DEL |
haematopoietic and lymphoid tissue |
Lymphoid neoplasm |
GSE36133/Sanger Cell Line Project |
| Detroit562 |
upper aerodigestive tract |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| DG-75 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
Sanger Cell Line Project |
| DJM-1 |
skin |
other |
Sanger Cell Line Project |
| DK-MG |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| DMS-114 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| DMS-153 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| DMS-273 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| DMS-53 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| DMS-79 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| DOHH-2 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| DOK |
upper aerodigestive tract |
epithelial dysplasia |
Sanger Cell Line Project |
| DoTc2-4510 |
cervix |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| DSH1 |
urinary tract |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| DU-145 |
prostate |
Epithelial neoplasms, NOS |
GSE36133/NCI60/Sanger Cell Line Project |
| DU-4475 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| DV-90 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| EB2 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| EB3 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
Sanger Cell Line Project |
| ECC10 |
stomach |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| ECC12 |
stomach |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| ECC4 |
gastrointestinal tract (site indeterminate) |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| EC-GI-10 |
oesophagus |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| EFM-19 |
breast |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| EFO-21 |
ovary |
Cystic, mucinous and serous neoplasms |
GSE36133/Sanger Cell Line Project |
| EFO-27 |
ovary |
Cystic, mucinous and serous neoplasms |
GSE36133/Sanger Cell Line Project |
| EGI-1 |
biliary tract |
Adenocarcinoma |
Sanger Cell Line Project |
| EHEB |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| EKVX |
lung |
Adenocarcinoma |
NCI60/Sanger Cell Line Project |
| EM-2 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| EOL-1 |
haematopoietic and lymphoid tissue |
Chronic myeloproliferative disorders |
GSE36133/Sanger Cell Line Project |
| EPLC-272H |
lung |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| ES1 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| ES3 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| ES5 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| ES6 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| ES7 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| ES8 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| ESS-1 |
endometrium |
Complex mixed and stromal neoplasms |
GSE36133/Sanger Cell Line Project |
| ETK-1 |
biliary tract |
Adenocarcinoma |
Sanger Cell Line Project |
| EVSA-T |
breast |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| EW-1 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-11 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-12 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-13 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-16 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-18 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-22 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-24 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-3 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| EW-7 |
bone |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| FaDu |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| FTC-133 |
thyroid |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| G-361 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| G-401 |
kidney |
Complex mixed and stromal neoplasms |
GSE36133/Sanger Cell Line Project |
| GA-10-Clone-20 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
Sanger Cell Line Project |
| GA-10-Clone-4 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
Sanger Cell Line Project |
| GAK |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| GAMG |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| GCIY |
stomach |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| GCT |
soft tissue |
Malignant fibrous histiocytoma and pleomorphic sarcoma |
GSE36133/Sanger Cell Line Project |
| GDM-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| GI-1 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| GI-ME-N |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| GMS-10 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| GOTO |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| GOTO-P3 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| GP2d |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| GP5d |
large intestine |
Adenocarcinoma |
Sanger Cell Line Project |
| GR-ST |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| GT3TKB |
stomach |
Adenocarcinoma |
Sanger Cell Line Project |
| H4 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| H9 |
haematopoietic and lymphoid tissue |
Mature T- and NK-cell lymphomas |
Sanger Cell Line Project |
| HA7-RCC |
kidney |
Adenocarcinoma |
Sanger Cell Line Project |
| HAL-01 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| HC-1 |
haematopoietic and lymphoid tissue |
Other leukemias |
Sanger Cell Line Project |
| HCC1143 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC1187 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC1395 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC1419 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC1599 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC1806 |
breast |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC1937 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC1954 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC2157 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC2218 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC2998 |
large intestine |
Adenocarcinoma |
NCI60/Sanger Cell Line Project |
| HCC38 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCC70 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HCE-4 |
oesophagus |
Squamous cell neoplasms |
Sanger Cell Line Project |
| HCE-T |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| HCT-116 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133/NCI60/Sanger Cell Line Project |
| HCT-15 |
large intestine |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| HDLM-2 |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133/Sanger Cell Line Project |
| HD-MY-Z |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133/Sanger Cell Line Project |
| HEC-1 |
endometrium |
Adenocarcinoma |
Sanger Cell Line Project |
| HEL |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| HeLaSF |
cervix |
Adenocarcinoma |
Sanger Cell Line Project |
| H-EMC-SS |
bone |
Osseous and chondromatous neoplasms |
Sanger Cell Line Project |
| HGC-27 |
stomach |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| HH |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| HL-60 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/NCI60/Sanger Cell Line Project |
| HLE |
liver |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| HMV-II |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| HN |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| HO-1-N-1 |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| HOP-62 |
lung |
Adenocarcinoma |
NCI60/Sanger Cell Line Project |
| HOP-92 |
lung |
Epithelial neoplasms, NOS |
NCI60/Sanger Cell Line Project |
| HOS |
bone |
Osseous and chondromatous neoplasms |
GSE36133/Sanger Cell Line Project |
| HPAF-II |
pancreas |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| HS578T |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/NCI60/Sanger Cell Line Project |
| HSC-2 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| HSC-3 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| HSC-4 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| HT |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| HT-1080 |
soft tissue |
Fibromatous neoplasms |
GSE36133/Sanger Cell Line Project |
| HT-1197 |
urinary tract |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| HT-1376 |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| HT-144 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| HT-29 |
large intestine |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| HT-3 |
cervix |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| HT-55 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| HTC-C3 |
thyroid |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| HuCCT1 |
biliary tract |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| HuH-28 |
biliary tract |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| HuH-6-clone5 |
liver |
Adenocarcinoma |
Sanger Cell Line Project |
| HuH-7 |
liver |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| HuNS1 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133/Sanger Cell Line Project |
| HuO-3N1 |
bone |
Osseous and chondromatous neoplasms |
Sanger Cell Line Project |
| HuO9 |
bone |
Osseous and chondromatous neoplasms |
Sanger Cell Line Project |
| HuP-T3 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| HuP-T4 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| HUTU-80 |
small intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| IA-LM |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| IGR-1 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| IGROV-1 |
ovary |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| IM-9 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
Sanger Cell Line Project |
| IMR-5 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| IPC-298 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| IST-MEL1 |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| IST-MES1 |
pleura |
Mesothelial neoplasms |
GSE36133/Sanger Cell Line Project |
| IST-SL1 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| IST-SL2 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| ITO-II |
testis |
Germ cell neoplasms |
Sanger Cell Line Project |
| J82 |
urinary tract |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| JAR |
placenta |
Trophoblastic neoplasms |
Sanger Cell Line Project |
| JEG-3 |
placenta |
Trophoblastic neoplasms |
Sanger Cell Line Project |
| JiyoyeP-2003 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
Sanger Cell Line Project |
| J-RT3-T3-5 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| JVM-2 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| JVM-3 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| K5 |
thyroid |
Adenocarcinoma |
Sanger Cell Line Project |
| KALS-1 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| KARPAS-299 |
haematopoietic and lymphoid tissue |
Mature T- and NK-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| KARPAS-422 |
haematopoietic and lymphoid tissue |
Malignant lymphoma |
Sanger Cell Line Project |
| KARPAS-45 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| KASUMI-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| KATOIII |
stomach |
Cystic, mucinous and serous neoplasms |
GSE36133/Sanger Cell Line Project |
| KE-37 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| KGN |
ovary |
Specialized gonadal neoplasms |
Sanger Cell Line Project |
| KINGS-1 |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| KLE |
endometrium |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| KM12 |
large intestine |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| KM-H2 |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133/Sanger Cell Line Project |
| KMOE-2 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
Sanger Cell Line Project |
| KMS-12-BM |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133/Sanger Cell Line Project |
| KMS-12-PE |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
Sanger Cell Line Project |
| KNS-42 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| KNS-62 |
lung |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KNS-81-FD |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| KO52 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| KOSC-2 |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| KP-4 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| KP-N-RT-BM-1 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| KP-N-SI9s |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| KP-N-YN |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| KP-N-YS |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| KS-1 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| KU-19-19 |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| KURAMOCHI |
ovary |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| KY821 |
haematopoietic and lymphoid tissue |
Leukemias, NOS |
Sanger Cell Line Project |
| KYSE-140 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-150 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-180 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-270 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-410 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-450 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-510 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-520 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| KYSE-70 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| L-363 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133/Sanger Cell Line Project |
| L-428 |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133/Sanger Cell Line Project |
| L-540 |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133/Sanger Cell Line Project |
| LAMA-84 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| LAN-1 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| LAN-5 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| LAN-6 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| LB1047-RCC |
kidney |
Adenocarcinoma |
Sanger Cell Line Project |
| LB2241-RCC |
kidney |
Adenocarcinoma |
Sanger Cell Line Project |
| LB2518-MEL |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| LB373-MEL-D |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| LB647-SCLC |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| LB771-HNC |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| LB831-BLC |
urinary tract |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| LB996-RCC |
kidney |
Adenocarcinoma |
Sanger Cell Line Project |
| LC-1F |
lung |
Squamous cell neoplasms |
Sanger Cell Line Project |
| LC4-1 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| LCLC-103H |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| LCLC-97TM1 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| LK-2 |
lung |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| LN-405 |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| LNCaP-Clone-FGC |
prostate |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| LOUCY |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| LoVo |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| LOXIMVI |
skin |
Nevi and melanomas |
GSE36133/NCI60/Sanger Cell Line Project |
| LP-1 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133/Sanger Cell Line Project |
| LS-1034 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| LS-123 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| LS-174T |
large intestine |
Adenocarcinoma |
Sanger Cell Line Project |
| LS-411N |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| LS-513 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| LU-134-A |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| LU-135 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| LU-139 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| LU-65 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| LU-99A |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| LXF-289 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| M059J |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| M14 |
skin |
Nevi and melanomas |
NCI60/Sanger Cell Line Project |
| MALME-3M |
skin |
Nevi and melanomas |
GSE36133/NCI60/Sanger Cell Line Project |
| MC-1010 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
Sanger Cell Line Project |
| MCF7 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/NCI60/Sanger Cell Line Project |
| MC-IXC |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| MDA-MB-134-VI |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| MDA-MB-157 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| MDA-MB-175-VII |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| MDA-MB-231 |
breast |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| MDA-MB-361 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| MDA-MB-415 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| MDA-MB-435 |
skin |
Nevi and melanomas |
NCI60/Sanger Cell Line Project |
| MDA-MB-453 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| MDA-MB-468 |
breast |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| ME-180 |
cervix |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| MEG-01 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| MEL-HO |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| MEL-JUSO |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| MES-SA |
soft tissue |
Soft tissue tumors and sarcomas, NOS |
Sanger Cell Line Project |
| MeWo |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| MFE-280 |
endometrium |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| MFE-296 |
endometrium |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| MFH-ino |
soft tissue |
Malignant fibrous histiocytoma and pleomorphic sarcoma |
Sanger Cell Line Project |
| MFM-223 |
breast |
Ductal, lobular and medullary neoplasms |
Sanger Cell Line Project |
| MG-63 |
bone |
Osseous and chondromatous neoplasms |
GSE36133/Sanger Cell Line Project |
| MHH-CALL-2 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| MHH-CALL-4 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| MHH-ES-1 |
bone |
Miscellaneous bone tumors |
GSE36133/Sanger Cell Line Project |
| MHH-NB-11 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| MHH-PREB-1 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| MIA-PaCa-2 |
pancreas |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| MJ |
haematopoietic and lymphoid tissue |
Mature T- and NK-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| MKN1 |
stomach |
Complex epithelial neoplasms |
GSE36133/Sanger Cell Line Project |
| MKN28 |
stomach |
Adenocarcinoma |
Sanger Cell Line Project |
| MKN45 |
stomach |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| MKN7 |
stomach |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| ML-2 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
Sanger Cell Line Project |
| MMAC-SF |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| MN-60 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| MOG-G-CCM |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| MOG-G-UVW |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| MOLT-13 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| MOLT-16 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| MOLT-4 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/NCI60/Sanger Cell Line Project |
| MONO-MAC-6 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| MPP-89 |
pleura |
Mesothelial neoplasms |
GSE36133/Sanger Cell Line Project |
| MRK-nu-1 |
breast |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| MS-1 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| MSTO-211H |
pleura |
Mesothelial neoplasms |
GSE36133/Sanger Cell Line Project |
| MUTZ-1 |
haematopoietic and lymphoid tissue |
Myelodysplastic syndrome |
Sanger Cell Line Project |
| MZ2-MEL |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| MZ7-MEL |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| NALM-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| NALM-6 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| NB1 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| NB10 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB12 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB13 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB14 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB16 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB17 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB19 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB4 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| NB5 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB6 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB69 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NB7 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NBsusSR |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NCCIT |
testis |
mixed |
Sanger Cell Line Project |
| NCI-ADR-RES |
ovary |
Cystic, mucinous and serous neoplasms |
NCI60/Sanger Cell Line Project |
| NCI-H1048 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1092 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1105 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1155 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1299 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1304 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H1355 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1395 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1436 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1437 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H146 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1522 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H1563 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H157 |
lung |
Squamous cell neoplasms |
Sanger Cell Line Project |
| NCI-H1573 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1618 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1650 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1651 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1666 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1693 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1703 |
lung |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| NCI-H1755 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1770 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H1792 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1793 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1838 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1926 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H1930 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H1975 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H1993 |
lung |
Adenocarcinoma |
Sanger Cell Line Project |
| NCI-H2009 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H2029 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H2030 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H2052 |
pleura |
Mesothelial neoplasms |
GSE36133/Sanger Cell Line Project |
| NCI-H2081 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H2087 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H209 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H2107 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H2126 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H2141 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H2170 |
lung |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| NCI-H2171 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H2196 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H2227 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H2228 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H226 |
lung |
Squamous cell neoplasms |
GSE36133/NCI60/Sanger Cell Line Project |
| NCI-H2291 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H23 |
lung |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| NCI-H2330 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H2342 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H2347 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H2405 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H2452 |
pleura |
Mesothelial neoplasms |
GSE36133/Sanger Cell Line Project |
| NCI-H250 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H28 |
pleura |
Mesothelial neoplasms |
GSE36133/Sanger Cell Line Project |
| NCI-H292 |
lung |
Mucoepidermoid neoplasms |
Sanger Cell Line Project |
| NCI-H295 |
adrenal gland |
Adenocarcinoma |
Sanger Cell Line Project |
| NCI-H345 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H358 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H378 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H441 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H446 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H460 |
lung |
Epithelial neoplasms, NOS |
GSE36133/NCI60/Sanger Cell Line Project |
| NCI-H508 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H510A |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H520 |
lung |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| NCI-H522 |
lung |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| NCI-H524 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H526 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H596 |
lung |
Complex epithelial neoplasms |
GSE36133/Sanger Cell Line Project |
| NCI-H630 |
large intestine |
Adenocarcinoma |
Sanger Cell Line Project |
| NCI-H64 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-H650 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H661 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H716 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H727 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H747 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-H810 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H82 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H838 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-H889 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NCI-N417 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-N87 |
stomach |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| NCI-SNU-1 |
stomach |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-SNU-16 |
stomach |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NCI-SNU-5 |
stomach |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| NEC8 |
testis |
Germ cell neoplasms |
Sanger Cell Line Project |
| NH-12 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| NH-6 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| NKM-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
Sanger Cell Line Project |
| NMC-G1 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| no-10 |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| no-11 |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| NOMO-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| NOS-1 |
bone |
Osseous and chondromatous neoplasms |
Sanger Cell Line Project |
| NTERA-S-cl-D1 |
testis |
Germ cell neoplasms |
Sanger Cell Line Project |
| NUGC-3 |
stomach |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| NY |
bone |
Osseous and chondromatous neoplasms |
Sanger Cell Line Project |
| OAW-28 |
ovary |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| OAW-42 |
ovary |
Cystic, mucinous and serous serous |
GSE36133/Sanger Cell Line Project |
| OC-314 |
ovary |
Cystic, mucinous and serous neoplasms |
GSE36133/Sanger Cell Line Project |
| OCI-AML2 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| OCUB-M |
breast |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| OE19 |
oesophagus |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| OE33 |
oesophagus |
metaplasia |
GSE36133/Sanger Cell Line Project |
| OMC-1 |
cervix |
Squamous cell neoplasms |
Sanger Cell Line Project |
| ONS-76 |
central nervous system |
Miscellaneous bone tumors |
GSE36133/Sanger Cell Line Project |
| OPM-2 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133/Sanger Cell Line Project |
| OS-RC-2 |
kidney |
Adenocarcinoma |
Sanger Cell Line Project |
| OVCAR-3 |
ovary |
Cystic, mucinous and serous neoplasms |
GSE36133/NCI60/Sanger Cell Line Project |
| OVCAR-4 |
ovary |
Cystic, mucinous and serous neoplasms |
GSE36133/NCI60/Sanger Cell Line Project |
| OVCAR-5 |
ovary |
Cystic, mucinous and serous neoplasms |
NCI60/Sanger Cell Line Project |
| OVCAR-8 |
ovary |
Epithelial neoplasms, NOS |
GSE36133/NCI60/Sanger Cell Line Project |
| P12-ICHIKAWA |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| P30-OHK |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| P31-FUJ |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| PA-1 |
ovary |
Germ cell neoplasms |
Sanger Cell Line Project |
| PANC-03-27 |
pancreas |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| PANC-08-13 |
pancreas |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| PANC-10-05 |
pancreas |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| PC-14 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| PC-3 |
prostate |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| PD1503a |
NA |
NA |
Sanger Cell Line Project |
| PF-382 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| PFSK-1 |
central nervous system |
Miscellaneous bone tumors |
Sanger Cell Line Project |
| PLC-PRF-5 |
liver |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| PSN1 |
pancreas |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| QIMR-WIL |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
Sanger Cell Line Project |
| Raji |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| Ramos-2G6-4C10 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
Sanger Cell Line Project |
| RCC10RGB |
kidney |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| RCM-1 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| RD |
soft tissue |
embryonal |
GSE36133/Sanger Cell Line Project |
| REH |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| RERF-LC-FM |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| RERF-LC-MS |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| RF-48 |
stomach |
Adenocarcinoma |
Sanger Cell Line Project |
| RH-1 |
soft tissue |
Myomatous neoplasms |
Sanger Cell Line Project |
| RH-18 |
soft tissue |
embryonal |
Sanger Cell Line Project |
| RKO |
large intestine |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| RL |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| RL95-2 |
endometrium |
Complex epithelial neoplasms |
GSE36133/Sanger Cell Line Project |
| RMG-I |
ovary |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| RO82-W-1 |
thyroid |
Adenocarcinoma |
Sanger Cell Line Project |
| RPMI-2650 |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| RPMI-6666 |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133/Sanger Cell Line Project |
| RPMI-7951 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| RPMI-8226 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133/NCI60/Sanger Cell Line Project |
| RPMI-8402 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| RPMI-8866 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
Sanger Cell Line Project |
| RS4-11 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| RT-112 |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| RTSG |
ovary |
Adenocarcinoma |
Sanger Cell Line Project |
| RVH-421 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| RXF-393 |
kidney |
Adenocarcinoma |
NCI60/Sanger Cell Line Project |
| S-117 |
soft tissue |
Soft tissue tumors and sarcomas, NOS |
GSE36133/Sanger Cell Line Project |
| Saos-2 |
bone |
Osseous and chondromatous neoplasms |
Sanger Cell Line Project |
| SAS |
upper aerodigestive tract |
Squamous cell neoplasms |
Sanger Cell Line Project |
| SBC-1 |
lung |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| SBC-5 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| SCC-15 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| SCC-25 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| SCC-3 |
haematopoietic and lymphoid tissue |
Malignant lymphoma |
Sanger Cell Line Project |
| SCC-4 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| SCC-9 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| SCCH-26 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| SCH |
stomach |
Trophoblastic neoplasms |
Sanger Cell Line Project |
| SCLC-21H |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| SF-126 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| SF-268 |
central nervous system |
Gliomas |
NCI60/Sanger Cell Line Project |
| SF-295 |
central nervous system |
Gliomas |
GSE36133/NCI60/Sanger Cell Line Project |
| SF-539 |
central nervous system |
Gliomas |
NCI60/Sanger Cell Line Project |
| SHP-77 |
lung |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| SiHa |
cervix |
Squamous cell neoplasms |
Sanger Cell Line Project |
| SIMA |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| SJRH30 |
soft tissue |
Myomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| SJSA-1 |
bone |
Osseous and chondromatous neoplasms |
GSE36133/Sanger Cell Line Project |
| SK-CO-1 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SKG-IIIa |
cervix |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| SK-HEP-1 |
liver |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SK-LMS-1 |
soft tissue |
Soft tissue tumors and sarcomas, NOS |
GSE36133/Sanger Cell Line Project |
| SK-LU-1 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SKM-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| SK-MEL-2 |
skin |
Nevi and melanomas |
GSE36133/NCI60/Sanger Cell Line Project |
| SK-MEL-24 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| SK-MEL-28 |
skin |
Nevi and melanomas |
GSE36133/NCI60/Sanger Cell Line Project |
| SK-MEL-3 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| SK-MEL-30 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| SK-MEL-5 |
skin |
Nevi and melanomas |
GSE36133/NCI60/Sanger Cell Line Project |
| SK-MES-1 |
lung |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| SK-MG-1 |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| SK-MM-2 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133/Sanger Cell Line Project |
| SK-N-AS |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| SK-N-DZ |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| SK-NEP-1 |
kidney |
Complex mixed and stromal neoplasms |
Sanger Cell Line Project |
| SK-N-FI |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| SK-OV-3 |
ovary |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| SK-UT-1 |
soft tissue |
Myomatous neoplasms |
GSE36133/Sanger Cell Line Project |
| SN12C |
kidney |
Adenocarcinoma |
NCI60/Sanger Cell Line Project |
| SNB-19 |
central nervous system |
Gliomas |
GSE36133/NCI60/Sanger Cell Line Project |
| SNG-M |
endometrium |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SNU-387 |
liver |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SNU-423 |
liver |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SNU-449 |
liver |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SNU-475 |
liver |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SNU-C1 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SNU-C2B |
large intestine |
Adenocarcinoma |
Sanger Cell Line Project |
| SR |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
NCI60/Sanger Cell Line Project |
| ST486 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| SU-DHL-1 |
haematopoietic and lymphoid tissue |
Mature T- and NK-cell lymphomas |
GSE36133/Sanger Cell Line Project |
| SUP-B8 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| SUP-T1 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| SW1088 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| SW1116 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SW13 |
adrenal gland |
Adenocarcinoma |
Sanger Cell Line Project |
| SW1417 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SW1463 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SW1573 |
lung |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SW1710 |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| SW1783 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| SW1990 |
pancreas |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SW403 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SW48 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SW620 |
large intestine |
Adenocarcinoma |
GSE36133/NCI60/Sanger Cell Line Project |
| SW626 |
ovary |
Adenocarcinoma |
Sanger Cell Line Project |
| SW684 |
soft tissue |
Fibromatous neoplasms |
Sanger Cell Line Project |
| SW780 |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| SW837 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SW872 |
soft tissue |
Lipomatous neoplsms |
Sanger Cell Line Project |
| SW900 |
lung |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| SW948 |
large intestine |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| SW954 |
vulva |
Squamous cell neoplasms |
Sanger Cell Line Project |
| SW962 |
vulva |
Squamous cell neoplasms |
Sanger Cell Line Project |
| SW982 |
soft tissue |
Synovial-like neoplsms |
Sanger Cell Line Project |
| T-24 |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| T47D |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/NCI60/Sanger Cell Line Project |
| T84 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| T98G |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| TALL-1 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133/Sanger Cell Line Project |
| TCCSUP |
urinary tract |
Transitional cell papillomas and carcinomas |
Sanger Cell Line Project |
| TCO-1 |
thyroid |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| TC-YIK |
cervix |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| TE-1 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| TE-10 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| TE-11 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| TE-12 |
oesophagus |
Squamous cell neoplasms |
Sanger Cell Line Project |
| TE-15 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| TE-161-T |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
Sanger Cell Line Project |
| TE-5 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| TE-6 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| TE-8 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| TE-9 |
oesophagus |
Squamous cell neoplasms |
GSE36133/Sanger Cell Line Project |
| TGBC11TKB |
stomach |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| TGBC1TKB |
biliary tract |
Adenocarcinoma |
Sanger Cell Line Project |
| TGBC24TKB |
biliary tract |
Epithelial neoplasms, NOS |
Sanger Cell Line Project |
| TGW |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| THP-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/Sanger Cell Line Project |
| TI-73 |
bone |
Osseous and chondromatous neoplasms |
Sanger Cell Line Project |
| TK-10 |
kidney |
Adenocarcinoma |
NCI60/Sanger Cell Line Project |
| TT |
thyroid |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| TUR |
haematopoietic and lymphoid tissue |
Malignant lymphoma |
Sanger Cell Line Project |
| TYK-nu |
ovary |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| U031 |
kidney |
Adenocarcinoma |
Sanger Cell Line Project |
| U-118-MG |
central nervous system |
Gliomas |
Sanger Cell Line Project |
| U251 |
central nervous system |
Gliomas |
NCI60/Sanger Cell Line Project |
| U-266 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
Sanger Cell Line Project |
| U-2-OS |
bone |
Osseous and chondromatous neoplasms |
GSE36133/Sanger Cell Line Project |
| U-698-M |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
Sanger Cell Line Project |
| U-87-MG |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| UACC-257 |
skin |
Nevi and melanomas |
GSE36133/NCI60/Sanger Cell Line Project |
| UACC-62 |
skin |
Nevi and melanomas |
GSE36133/NCI60/Sanger Cell Line Project |
| UACC-812 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| UMC-11 |
lung |
Adenocarcinoma |
Sanger Cell Line Project |
| UM-UC-3 |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| VA-ES-BJ |
soft tissue |
Soft tissue tumors and sarcomas, NOS |
Sanger Cell Line Project |
| VM-CUB1 |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133/Sanger Cell Line Project |
| VMRC-MELG |
skin |
Nevi and melanomas |
Sanger Cell Line Project |
| VMRC-RCZ |
kidney |
Adenocarcinoma |
GSE36133/Sanger Cell Line Project |
| WERI-Rb-1 |
eye |
Neuroepitheliomatous neoplasms |
Sanger Cell Line Project |
| WM-115 |
skin |
Nevi and melanomas |
GSE36133/Sanger Cell Line Project |
| WSU-NHL |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
Sanger Cell Line Project |
| YAPC |
pancreas |
Epithelial neoplasms, NOS |
GSE36133/Sanger Cell Line Project |
| YH-13 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| YKG-1 |
central nervous system |
Gliomas |
GSE36133/Sanger Cell Line Project |
| ZR-75-30 |
breast |
Ductal, lobular and medullary neoplasms |
GSE36133/Sanger Cell Line Project |
| SNB-75 |
central nervous system |
Gliomas |
NCI60 |
| K-562 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133/NCI60 |
| NCI-H322M |
lung |
Adenocarcinoma |
NCI60 |
| UO-31 |
kidney |
Adenocarcinoma |
NCI60 |
| 1321N1 |
central nervous system |
Gliomas |
GSE36133 |
| 143B |
bone |
Osseous and chondromatous neoplasms |
GSE36133 |
| 42-MG-BA |
central nervous system |
Gliomas |
GSE36133 |
| 8305C |
thyroid |
Epithelial neoplasms, NOS |
GSE36133 |
| ACC-MESO-1 |
pleura |
Mesothelial neoplasms |
GSE36133 |
| AlexanderCells |
liver |
Adenocarcinoma |
GSE36133 |
| AMO-1 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| AU565 |
breast |
Epithelial neoplasms, NOS |
GSE36133 |
| AZ-521 |
stomach |
Epithelial neoplasms, NOS |
GSE36133 |
| BC-3C |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133 |
| BCP-1 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| BDCM |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| BICR16 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| BICR18 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| BICR22 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| BICR31 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| BICR56 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| BICR6 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| BT-474 |
breast |
Adenocarcinoma |
GSE36133 |
| BT-483 |
breast |
Adenocarcinoma |
GSE36133 |
| CADO-ES1 |
bone |
Miscellaneous bone tumors |
GSE36133 |
| CAKI-2 |
kidney |
Adenocarcinoma |
GSE36133 |
| CAL-29 |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133 |
| CAL-78 |
bone |
dedifferentiated |
GSE36133 |
| CAPAN-2 |
pancreas |
Adenocarcinoma |
GSE36133 |
| CCK-81 |
large intestine |
Adenocarcinoma |
GSE36133 |
| CI-1 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| CJM |
skin |
Nevi and melanomas |
GSE36133 |
| CL-11 |
large intestine |
Adenocarcinoma |
GSE36133 |
| CL-14 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133 |
| CL-34 |
large intestine |
Adenocarcinoma |
GSE36133 |
| CL-40 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133 |
| CMK-11-5 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| COLO-320 |
large intestine |
Adenocarcinoma |
GSE36133 |
| COLO-699 |
lung |
Adenocarcinoma |
GSE36133 |
| COLO-704 |
ovary |
Epithelial neoplasms, NOS |
GSE36133 |
| COLO-783 |
skin |
Nevi and melanomas |
GSE36133 |
| COLO-818 |
skin |
Nevi and melanomas |
GSE36133 |
| COLO829 |
skin |
Nevi and melanomas |
GSE36133 |
| COLO-849 |
skin |
Nevi and melanomas |
GSE36133 |
| COR-L24 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| COR-L311 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| COR-L47 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| COR-L95 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| COV318 |
ovary |
Epithelial neoplasms, NOS |
GSE36133 |
| COV362 |
ovary |
Epithelial neoplasms, NOS |
GSE36133 |
| COV434 |
ovary |
Specialized gonadal neoplasms |
GSE36133 |
| COV504 |
ovary |
Epithelial neoplasms, NOS |
GSE36133 |
| COV644 |
ovary |
Epithelial neoplasms, NOS |
GSE36133 |
| D-341MED |
central nervous system |
Miscellaneous bone tumors |
GSE36133 |
| DAN-G |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| DLD-1 |
large intestine |
Adenocarcinoma |
GSE36133 |
| DMS-454 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| DND-41 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| EB1 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| EBC-1 |
lung |
Squamous cell neoplasms |
GSE36133 |
| EFE-184 |
endometrium |
Epithelial neoplasms, NOS |
GSE36133 |
| EFM-192A |
breast |
Epithelial neoplasms, NOS |
GSE36133 |
| EJM |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| EN |
endometrium |
Epithelial neoplasms, NOS |
GSE36133 |
| ES-2 |
ovary |
Adenocarcinoma |
GSE36133 |
| F-36P |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| FU97 |
stomach |
Adenocarcinoma |
GSE36133 |
| FU-OV-1 |
ovary |
Cystic, mucinous and serous neoplasms |
GSE36133 |
| G-292-Clone-A141B1 |
bone |
Osseous and chondromatous neoplasms |
GSE36133 |
| G-402 |
soft tissue |
Complex mixed and stromal neoplasms |
GSE36133 |
| GA-10 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| GOS-3 |
central nervous system |
Gliomas |
GSE36133 |
| GRANTA-519 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| GSS |
stomach |
Adenocarcinoma |
GSE36133 |
| GSU |
stomach |
Adenocarcinoma |
GSE36133 |
| HARA |
lung |
Squamous cell neoplasms |
GSE36133 |
| HCC1171 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| HCC1195 |
lung |
Complex epithelial neoplasms |
GSE36133 |
| HCC1428 |
breast |
Epithelial neoplasms, NOS |
GSE36133 |
| HCC1500 |
breast |
Adenocarcinoma |
GSE36133 |
| HCC1569 |
breast |
Complex epithelial neoplasms |
GSE36133 |
| HCC15 |
lung |
Squamous cell neoplasms |
GSE36133 |
| HCC202 |
breast |
Adenocarcinoma |
GSE36133 |
| HCC2279 |
lung |
Adenocarcinoma |
GSE36133 |
| HCC2935 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| HCC33 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| HCC366 |
lung |
Complex epithelial neoplasms |
GSE36133 |
| HCC4006 |
lung |
Adenocarcinoma |
GSE36133 |
| HCC44 |
lung |
Adenocarcinoma |
GSE36133 |
| HCC56 |
large intestine |
Adenocarcinoma |
GSE36133 |
| HCC78 |
lung |
Adenocarcinoma |
GSE36133 |
| HCC827 |
lung |
Adenocarcinoma |
GSE36133 |
| HCC95 |
lung |
Squamous cell neoplasms |
GSE36133 |
| HDQ-P1 |
breast |
Adenocarcinoma |
GSE36133 |
| HEC-108 |
endometrium |
Adenocarcinoma |
GSE36133 |
| HEC-151 |
endometrium |
Adenocarcinoma |
GSE36133 |
| HEC-1-A |
endometrium |
Adenocarcinoma |
GSE36133 |
| HEC-1-B |
endometrium |
Adenocarcinoma |
GSE36133 |
| HEC-251 |
endometrium |
Adenocarcinoma |
GSE36133 |
| HEC-265 |
endometrium |
Adenocarcinoma |
GSE36133 |
| HEC-50B |
endometrium |
Adenocarcinoma |
GSE36133 |
| HEC-59 |
endometrium |
Adenocarcinoma |
GSE36133 |
| HEC-6 |
endometrium |
Adenocarcinoma |
GSE36133 |
| HEL92.1.7 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| Hep3B2.1-7 |
liver |
Adenocarcinoma |
GSE36133 |
| HepG2 |
liver |
Adenocarcinoma |
GSE36133 |
| Hey-A8 |
ovary |
Epithelial neoplasms, NOS |
GSE36133 |
| HLF-a |
lung |
Squamous cell neoplasms |
GSE36133 |
| HLF |
liver |
Adenocarcinoma |
GSE36133 |
| HMCB |
skin |
Nevi and melanomas |
GSE36133 |
| HPAC |
pancreas |
Adenocarcinoma |
GSE36133 |
| HPB-ALL |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| HS172T |
urinary tract |
Epithelial neoplasms, NOS |
GSE36133 |
| HS229T |
lung |
Adenocarcinoma |
GSE36133 |
| HS274T |
breast |
Epithelial neoplasms, NOS |
GSE36133 |
| HS281T |
breast |
Epithelial neoplasms, NOS |
GSE36133 |
| HS294T |
skin |
Nevi and melanomas |
GSE36133 |
| HS343T |
breast |
Epithelial neoplasms, NOS |
GSE36133 |
| HS600T |
skin |
Nevi and melanomas |
GSE36133 |
| HS604T |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133 |
| HS606T |
breast |
Epithelial neoplasms, NOS |
GSE36133 |
| HS611T |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133 |
| HS616T |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133 |
| HS618T |
lung |
Adenocarcinoma |
GSE36133 |
| HS675T |
large intestine |
Epithelial neoplasms, NOS |
GSE36133 |
| HS683 |
central nervous system |
Gliomas |
GSE36133 |
| HS688AT |
skin |
Nevi and melanomas |
GSE36133 |
| HS695T |
skin |
Nevi and melanomas |
GSE36133 |
| HS698T |
large intestine |
Adenocarcinoma |
GSE36133 |
| HS706T |
bone |
Giant cell tumors |
GSE36133 |
| HS729 |
soft tissue |
Myomatous neoplasms |
GSE36133 |
| HS737T |
bone |
Giant cell tumors |
GSE36133 |
| HS739T |
breast |
Epithelial neoplasms, NOS |
GSE36133 |
| HS742T |
breast |
Epithelial neoplasms, NOS |
GSE36133 |
| HS746T |
stomach |
Epithelial neoplasms, NOS |
GSE36133 |
| HS751T |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133 |
| HS766T |
pancreas |
Adenocarcinoma |
GSE36133 |
| HS819T |
bone |
Osseous and chondromatous neoplasms |
GSE36133 |
| HS821T |
bone |
Giant cell tumors |
GSE36133 |
| HS822T |
bone |
Miscellaneous bone tumors |
GSE36133 |
| HS839T |
skin |
Nevi and melanomas |
GSE36133 |
| HS840T |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| HS852T |
skin |
Nevi and melanomas |
GSE36133 |
| HS863T |
bone |
Miscellaneous bone tumors |
GSE36133 |
| HS870T |
bone |
Osseous and chondromatous neoplasms |
GSE36133 |
| HS888T |
bone |
Osseous and chondromatous neoplasms |
GSE36133 |
| HS895T |
skin |
Nevi and melanomas |
GSE36133 |
| HS934T |
skin |
Nevi and melanomas |
GSE36133 |
| HS936T |
skin |
Nevi and melanomas |
GSE36133 |
| HS939T |
skin |
Nevi and melanomas |
GSE36133 |
| HS940T |
skin |
Nevi and melanomas |
GSE36133 |
| HS944T |
skin |
Nevi and melanomas |
GSE36133 |
| HT-115 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133 |
| HuG1-N |
stomach |
Epithelial neoplasms, NOS |
GSE36133 |
| HuH-1 |
liver |
Adenocarcinoma |
GSE36133 |
| HuH-6 |
liver |
Complex mixed and stromal neoplasms |
GSE36133 |
| HuT102 |
haematopoietic and lymphoid tissue |
Mature T- and NK-cell lymphomas |
GSE36133 |
| HuT78 |
haematopoietic and lymphoid tissue |
Mature T- and NK-cell lymphomas |
GSE36133 |
| IGR-37 |
skin |
Nevi and melanomas |
GSE36133 |
| IGR-39 |
skin |
Nevi and melanomas |
GSE36133 |
| IM-95 |
stomach |
Adenocarcinoma |
GSE36133 |
| IMR-32 |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133 |
| Ishikawa(Heraklio)02ER- |
endometrium |
Adenocarcinoma |
GSE36133 |
| IST-MES2 |
pleura |
Mesothelial neoplasms |
GSE36133 |
| JeKo-1 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| JHH-1 |
liver |
Adenocarcinoma |
GSE36133 |
| JHH-2 |
liver |
Adenocarcinoma |
GSE36133 |
| JHH-4 |
liver |
Adenocarcinoma |
GSE36133 |
| JHH-5 |
liver |
Adenocarcinoma |
GSE36133 |
| JHH-6 |
liver |
Adenocarcinoma |
GSE36133 |
| JHH-7 |
liver |
Adenocarcinoma |
GSE36133 |
| JHOC-5 |
ovary |
Adenocarcinoma |
GSE36133 |
| JHOM-1 |
ovary |
Adenocarcinoma |
GSE36133 |
| JHOM-2B |
ovary |
Adenocarcinoma |
GSE36133 |
| JHOS-2 |
ovary |
Adenocarcinoma |
GSE36133 |
| JHOS-4 |
ovary |
Adenocarcinoma |
GSE36133 |
| JHUEM-1 |
endometrium |
Adenocarcinoma |
GSE36133 |
| JHUEM-2 |
endometrium |
Adenocarcinoma |
GSE36133 |
| JHUEM-3 |
endometrium |
Adenocarcinoma |
GSE36133 |
| JIMT-1 |
breast |
Adenocarcinoma |
GSE36133 |
| JK-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| JL-1 |
pleura |
Mesothelial neoplasms |
GSE36133 |
| JM1 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| JMSU-1 |
urinary tract |
Epithelial neoplasms, NOS |
GSE36133 |
| JURKAT |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| JURL-MK1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| K029AX |
skin |
Nevi and melanomas |
GSE36133 |
| KARPAS-620 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| KASUMI-2 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| KASUMI-6 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| KCI-MOH1 |
pancreas |
Adenocarcinoma |
GSE36133 |
| KCL-22 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| KE-39 |
stomach |
Epithelial neoplasms, NOS |
GSE36133 |
| KE-97 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| KELLY |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133 |
| KG-1-C |
central nervous system |
Gliomas |
GSE36133 |
| KG-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| KHM-1B |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| Ki-JK |
haematopoietic and lymphoid tissue |
Mature T- and NK-cell lymphomas |
GSE36133 |
| KMBC-2 |
urinary tract |
Epithelial neoplasms, NOS |
GSE36133 |
| KMM-1 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| KMRC-1 |
kidney |
Adenocarcinoma |
GSE36133 |
| KMRC-20 |
kidney |
Adenocarcinoma |
GSE36133 |
| KMRC-2 |
kidney |
Adenocarcinoma |
GSE36133 |
| KMRC-3 |
kidney |
Adenocarcinoma |
GSE36133 |
| KMS-11 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| KMS-18 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| KMS-20 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| KMS-21-BM |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| KMS-26 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| KMS-27 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| KMS-28BM |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| KMS-34 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| KNS-60 |
central nervous system |
Gliomas |
GSE36133 |
| KNS-81 |
central nervous system |
Gliomas |
GSE36133 |
| KOPN-8 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| KP-2 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| KP-3 |
pancreas |
Adenocarcinoma |
GSE36133 |
| KPL-1 |
breast |
Adenocarcinoma |
GSE36133 |
| KU812 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| KYM-1 |
soft tissue |
Myomatous neoplasms |
GSE36133 |
| KYO-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| KYSE-30 |
oesophagus |
Squamous cell neoplasms |
GSE36133 |
| L-1236 |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133 |
| L3.3 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| LC-1-sq-SF |
lung |
Squamous cell neoplasms |
GSE36133 |
| Li-7 |
liver |
Adenocarcinoma |
GSE36133 |
| LMSU |
stomach |
Adenocarcinoma |
GSE36133 |
| LN-18 |
central nervous system |
Gliomas |
GSE36133 |
| LN-229 |
central nervous system |
Gliomas |
GSE36133 |
| LOU-NH91 |
lung |
Squamous cell neoplasms |
GSE36133 |
| LS-180 |
large intestine |
Adenocarcinoma |
GSE36133 |
| LU-99 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| LUDLU-1 |
lung |
Squamous cell neoplasms |
GSE36133 |
| M059K |
central nervous system |
Gliomas |
GSE36133 |
| M-07e |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| MC-116 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| MCAS |
ovary |
Adenocarcinoma |
GSE36133 |
| MDA-MB-435S |
skin |
Nevi and melanomas |
GSE36133 |
| MDA-MB-436 |
breast |
Epithelial neoplasms, NOS |
GSE36133 |
| MDAPCa2b |
prostate |
Adenocarcinoma |
GSE36133 |
| MDST8 |
large intestine |
Adenocarcinoma |
GSE36133 |
| ME-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| MEC-1 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| MEC-2 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| MFE-319 |
endometrium |
Adenocarcinoma |
GSE36133 |
| MHH-CALL-3 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| Mino |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| MKN74 |
stomach |
Adenocarcinoma |
GSE36133 |
| ML-1 |
thyroid |
Adenocarcinoma |
GSE36133 |
| MM1-S |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| MOLM-13 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| MOLM-16 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| MOLM-6 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| MOLP-2 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| MOLP-8 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| MONO-MAC-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| MOR-CPR |
lung |
Adenocarcinoma |
GSE36133 |
| MOTN-1 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| MUTZ-5 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| MV-4-11 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| NALM-19 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| NCI-H1184 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H1339 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H1341 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H1373 |
lung |
Adenocarcinoma |
GSE36133 |
| NCI-H1385 |
lung |
Squamous cell neoplasms |
GSE36133 |
| NCI-H1435 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H1568 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H1581 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H1623 |
lung |
Adenocarcinoma |
GSE36133 |
| NCI-H1648 |
lung |
Adenocarcinoma |
GSE36133 |
| NCI-H1694 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H1734 |
lung |
Adenocarcinoma |
GSE36133 |
| NCI-H1781 |
lung |
Adenocarcinoma |
GSE36133 |
| NCI-H1836 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H1869 |
lung |
Squamous cell neoplasms |
GSE36133 |
| NCI-H1876 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H1915 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H1944 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H1963 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H196 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H2023 |
lung |
Adenocarcinoma |
GSE36133 |
| NCI-H2066 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H2085 |
lung |
Adenocarcinoma |
GSE36133 |
| NCI-H2106 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H2110 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H211 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H2122 |
lung |
Adenocarcinoma |
GSE36133 |
| NCI-H2172 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H2286 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H2444 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H322 |
lung |
Adenocarcinoma |
GSE36133 |
| NCI-H510 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H647 |
lung |
Complex epithelial neoplasms |
GSE36133 |
| NCI-H660 |
prostate |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H69 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H841 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| NCI-H854 |
lung |
Adenocarcinoma |
GSE36133 |
| NCI-H929 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| NCO2 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| NU-DHL-1 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| NU-DUL-1 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| NUGC-2 |
stomach |
Adenocarcinoma |
GSE36133 |
| NUGC-4 |
stomach |
Cystic, mucinous and serous neoplasms |
GSE36133 |
| OC-316 |
ovary |
Adenocarcinoma |
GSE36133 |
| OCI-AML3 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| OCI-AML5 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| OCI-LY-19 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| OCI-LY3 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| OCI-M1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| OCUM-1 |
stomach |
Adenocarcinoma |
GSE36133 |
| OUMS-23 |
large intestine |
Adenocarcinoma |
GSE36133 |
| OUMS-27 |
bone |
Osseous and chondromatous neoplasms |
GSE36133 |
| OV56 |
ovary |
Epithelial neoplasms, NOS |
GSE36133 |
| OV7 |
ovary |
Epithelial neoplasms, NOS |
GSE36133 |
| OV90 |
ovary |
Complex epithelial neoplasms |
GSE36133 |
| OVK18 |
ovary |
Adenocarcinoma |
GSE36133 |
| OVKATE |
ovary |
Adenocarcinoma |
GSE36133 |
| OVMANA |
ovary |
Adenocarcinoma |
GSE36133 |
| OVSAHO |
ovary |
Adenocarcinoma |
GSE36133 |
| OVTOKO |
ovary |
Adenocarcinoma |
GSE36133 |
| P3HR-1 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| PANC-02-03 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| PANC-02-13 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| PANC-04-03 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| PANC-05-04 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| PANC-1 |
pancreas |
Adenocarcinoma |
GSE36133 |
| PA-TU-8902 |
pancreas |
Adenocarcinoma |
GSE36133 |
| PA-TU-8988S |
pancreas |
Adenocarcinoma |
GSE36133 |
| PA-TU-8988T |
pancreas |
Adenocarcinoma |
GSE36133 |
| PCM6 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| PE-CA-PJ15 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| PE-CA-PJ34(cloneC12) |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| PE-CA-PJ41(cloneD2) |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| PE-CA-PJ49 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| PEER |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| Pfeiffer |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| PK-1 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| PK-45H |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| PK-59 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| PL-21 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| PL45 |
pancreas |
Adenocarcinoma |
GSE36133 |
| QGP-1 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| RCH-ACV |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| RD-ES |
bone |
Miscellaneous bone tumors |
GSE36133 |
| REC-1 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| RERF-GC-1B |
stomach |
Epithelial neoplasms, NOS |
GSE36133 |
| RERF-LC-Ad1 |
lung |
Adenocarcinoma |
GSE36133 |
| RERF-LC-Ad2 |
lung |
Adenocarcinoma |
GSE36133 |
| RERF-LC-AI |
lung |
Squamous cell neoplasms |
GSE36133 |
| RERF-LC-KJ |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| RERF-LC-Sq1 |
lung |
Squamous cell neoplasms |
GSE36133 |
| RH-41 |
soft tissue |
Adenocarcinoma |
GSE36133 |
| RI-1 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| RKN |
soft tissue |
Myomatous neoplasms |
GSE36133 |
| RMUG-S |
ovary |
Adenocarcinoma |
GSE36133 |
| RT112-84 |
urinary tract |
Epithelial neoplasms, NOS |
GSE36133 |
| RT4 |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133 |
| SCaBER |
urinary tract |
Transitional cell papillomas and carcinomas |
GSE36133 |
| SEM |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| Set-2 |
haematopoietic and lymphoid tissue |
Chronic myeloproliferative disorders |
GSE36133 |
| SH-10-TC |
stomach |
Epithelial neoplasms, NOS |
GSE36133 |
| SH-4 |
skin |
Nevi and melanomas |
GSE36133 |
| SH-SY5Y |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133 |
| SIG-M5 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| SK-BR-3 |
breast |
Epithelial neoplasms, NOS |
GSE36133 |
| SK-ES-1 |
bone |
Miscellaneous bone tumors |
GSE36133 |
| SK-MEL-1 |
skin |
Nevi and melanomas |
GSE36133 |
| SK-MEL-31 |
skin |
Nevi and melanomas |
GSE36133 |
| SK-N-BE(2) |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133 |
| SK-N-MC |
bone |
Miscellaneous bone tumors |
GSE36133 |
| SK-N-SH |
autonomic ganglia |
Neuroepitheliomatous neoplasms |
GSE36133 |
| SNU-1040 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-1076 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| SNU-1077 |
endometrium |
Complex mixed and stromal neoplasms |
GSE36133 |
| SNU-1079 |
biliary tract |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-1105 |
central nervous system |
Gliomas |
GSE36133 |
| SNU-1196 |
biliary tract |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-119 |
ovary |
Adenocarcinoma |
GSE36133 |
| SNU-1214 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| SNU-1272 |
kidney |
Adenocarcinoma |
GSE36133 |
| SNU-16 |
stomach |
Squamous cell neoplasms |
GSE36133 |
| SNU-175 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-182 |
liver |
Adenocarcinoma |
GSE36133 |
| SNU-1 |
stomach |
Squamous cell neoplasms |
GSE36133 |
| SNU-201 |
central nervous system |
Gliomas |
GSE36133 |
| SNU-213 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-216 |
stomach |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-245 |
biliary tract |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-283 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-308 |
biliary tract |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-324 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-398 |
liver |
Adenocarcinoma |
GSE36133 |
| SNU-407 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-410 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-466 |
central nervous system |
Gliomas |
GSE36133 |
| SNU-46 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| SNU-478 |
biliary tract |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-503 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-520 |
stomach |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-5 |
stomach |
Squamous cell neoplasms |
GSE36133 |
| SNU-61 |
large intestine |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-620 |
stomach |
Epithelial neoplasms, NOS |
GSE36133 |
| SNU-626 |
central nervous system |
Gliomas |
GSE36133 |
| SNU-738 |
central nervous system |
Gliomas |
GSE36133 |
| SNU-761 |
liver |
Adenocarcinoma |
GSE36133 |
| SNU-840 |
ovary |
Fibroepithelial neoplasms |
GSE36133 |
| SNU-878 |
liver |
Adenocarcinoma |
GSE36133 |
| SNU-899 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| SNU-C2A |
large intestine |
Adenocarcinoma |
GSE36133 |
| SNU-C4 |
large intestine |
Adenocarcinoma |
GSE36133 |
| SNU-C5 |
large intestine |
Adenocarcinoma |
GSE36133 |
| Sq-1 |
lung |
Squamous cell neoplasms |
GSE36133 |
| SR-786 |
haematopoietic and lymphoid tissue |
Mature T- and NK-cell lymphomas |
GSE36133 |
| SU.86.86 |
pancreas |
Adenocarcinoma |
GSE36133 |
| SU-DHL-10 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| SU-DHL-4 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| SU-DHL-5 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| SU-DHL-6 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| SU-DHL-8 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| SUIT-2 |
pancreas |
Adenocarcinoma |
GSE36133 |
| SUP-B15 |
haematopoietic and lymphoid tissue |
Lymphoid leukemias |
GSE36133 |
| SUP-HD1 |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133 |
| SUP-M2 |
haematopoietic and lymphoid tissue |
Mature T- and NK-cell lymphomas |
GSE36133 |
| SUP-T11 |
haematopoietic and lymphoid tissue |
Mature T- and NK-cell lymphomas |
GSE36133 |
| SW1271 |
lung |
Epithelial neoplasms, NOS |
GSE36133 |
| SW1353 |
bone |
Osseous and chondromatous neoplasms |
GSE36133 |
| SW480 |
large intestine |
Adenocarcinoma |
GSE36133 |
| SW579 |
thyroid |
Epithelial neoplasms, NOS |
GSE36133 |
| T1-73 |
bone |
Osseous and chondromatous neoplasms |
GSE36133 |
| T3M-4 |
pancreas |
Adenocarcinoma |
GSE36133 |
| TC-71 |
bone |
Miscellaneous bone tumors |
GSE36133 |
| TCC-PAN2 |
pancreas |
Epithelial neoplasms, NOS |
GSE36133 |
| TE-14 |
oesophagus |
Squamous cell neoplasms |
GSE36133 |
| TE441T |
soft tissue |
Myomatous neoplasms |
GSE36133 |
| TE-4 |
oesophagus |
Squamous cell neoplasms |
GSE36133 |
| TE617T |
soft tissue |
Myomatous neoplasms |
GSE36133 |
| TEN |
endometrium |
Adenocarcinoma |
GSE36133 |
| TF-1 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| TM-31 |
central nervous system |
Gliomas |
GSE36133 |
| TO175T |
haematopoietic and lymphoid tissue |
Hodgkin lymphoma |
GSE36133 |
| Toledo |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| TOV-112D |
ovary |
Adenocarcinoma |
GSE36133 |
| TOV-21G |
ovary |
Adenocarcinoma |
GSE36133 |
| TT2609-C02 |
thyroid |
Adenocarcinoma |
GSE36133 |
| T.T |
oesophagus |
Squamous cell neoplasms |
GSE36133 |
| TUHR10TKB |
kidney |
Epithelial neoplasms, NOS |
GSE36133 |
| TUHR14TKB |
kidney |
Epithelial neoplasms, NOS |
GSE36133 |
| TUHR4TKB |
kidney |
Epithelial neoplasms, NOS |
GSE36133 |
| U-138-MG |
central nervous system |
Gliomas |
GSE36133 |
| U-251-MG |
central nervous system |
Gliomas |
GSE36133 |
| U-266-B1 |
haematopoietic and lymphoid tissue |
Plasma cell tumors |
GSE36133 |
| U-937 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| UACC-893 |
breast |
Adenocarcinoma |
GSE36133 |
| UT-7 |
haematopoietic and lymphoid tissue |
Myeloid leukemias |
GSE36133 |
| VCaP |
prostate |
Adenocarcinoma |
GSE36133 |
| VMRC-RCW |
kidney |
Epithelial neoplasms, NOS |
GSE36133 |
| WM-1799 |
skin |
Nevi and melanomas |
GSE36133 |
| WM-266-4 |
skin |
Nevi and melanomas |
GSE36133 |
| WM-793 |
skin |
Nevi and melanomas |
GSE36133 |
| WM-88 |
skin |
Nevi and melanomas |
GSE36133 |
| WM-983B |
skin |
Nevi and melanomas |
GSE36133 |
| WSU-DLCL2 |
haematopoietic and lymphoid tissue |
Mature B-cell lymphomas |
GSE36133 |
| YD-10B |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| YD-15 |
salivary gland |
mucoepidermoid neoplasms |
GSE36133 |
| YD-38 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| YD-8 |
upper aerodigestive tract |
Squamous cell neoplasms |
GSE36133 |
| YMB-1 |
breast |
Epithelial neoplasms, NOS |
GSE36133 |
| ZR-75-1 |
breast |
Adenocarcinoma |
GSE36133 |